Clinical Trials Directory

Trials / Completed

CompletedNCT01314248

The Laryngeal Mask Airway (LMA) Unique and the Air-Q Intubating Laryngeal Airway (ILA) in Pediatric Patients

A Randomized Crossover Comparison Between the Air-Q Intubating Laryngeal Airway the Laryngeal Mask Airway-Unique in Children

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago · Academic / Other
Sex
All
Age
6 Months – 36 Months
Healthy volunteers
Accepted

Summary

The air-Q® intubating laryngeal airway (ILA) is an supraglottic device used for both airway maintenance during routine anesthesia and as a conduit for tracheal intubation for patients with a difficult airway. The investigators goal for this study is to compare the performance of the ILA with the current standard of care the standard LMA during routine anesthesia.

Detailed description

The goal for this randomized, crossover investigation is to compare a disposable version of the standard LMA, LMA Unique TM,with the air-Q ILA in pediatric patients. Oropharyngeal leak pressure is commonly used as an indicator of airway seal adequacy. Similarly, flexible fiberoptic bronchoscope examination is often employed to assess proper placement of airway devices. Our hypothesis is that the air-Q ILA is superior to the standard LMA in both these regards: 1. We hypothesize that airway leak pressures will be higher with the ILA. Airway leak pressures will be measured by recording the circuit pressure at which an equilibrium is reached. 2. We hypothesize that flexible fiberoptic view of the airway will be superior with the ILA. The airway view will be assessed using a previously used and published grading scale.

Conditions

Interventions

TypeNameDescription
DEVICEeach child will receive both the LMA and ILAeach child will receive both the size 2 LMA and size 1.5 ILA

Timeline

Start date
2010-12-01
Primary completion
2011-03-01
Completion
2011-03-01
First posted
2011-03-14
Last updated
2013-07-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01314248. Inclusion in this directory is not an endorsement.